Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Khiron Life Sciences Corp.
  6. News
  7. Summary
    KHRN   CA49374L3065

KHIRON LIFE SCIENCES CORP.

(KHRN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Khiron Life Sciences First Quarter Loss Narrows on Higher Medical Sales in Colombia

05/27/2021 | 05:27pm EDT


© MT Newswires 2021
All news about KHIRON LIFE SCIENCES CORP.
07/29KHIRON LIFE SCIENCES : Welcomes Dr. Eduardo Faveret as Medical Director for Braz..
PR
07/29Khiron Life Sciences Corp. Appoints Eduardo Faveret as Medical Director for Z..
CI
07/26KHIRON LIFE SCIENCES : Up 8.8% as Colombia Expands Medical Marijuana Program and..
MT
07/08KHIRON LIFE SCIENCES : Closes C$12.35 Million Private Placement of Share Units
MT
07/08KHIRON LIFE SCIENCES : Closes $12.3 Million Equity Financing
AQ
07/06UPDATE : Khiron Drops Near 15% as Details Proposed Offering of Securities
MT
07/06KHIRON LIFE SCIENCES : Announces Terms of Overnight Marketed Offering
AQ
07/06KHIRON LIFE SCIENCES : Details Proposed Offering of Securities
MT
07/06Khiron Life to Seek Acquisitions
CI
07/05KHIRON LIFE SCIENCES : Announces Proposed Offering of Securities
AQ
More news
Financials
Sales 2021 15,3 M 12,3 M 12,3 M
Net income 2021 -22,2 M -17,8 M -17,8 M
Net cash 2021 11,0 M 8,82 M 8,82 M
P/E ratio 2021 -1,53x
Yield 2021 -
Capitalization 54,6 M 43,8 M 43,8 M
EV / Sales 2021 2,85x
EV / Sales 2022 0,97x
Nbr of Employees -
Free-Float 94,7%
Chart KHIRON LIFE SCIENCES CORP.
Duration : Period :
Khiron Life Sciences Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KHIRON LIFE SCIENCES CORP.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 0,31 CAD
Average target price 0,95 CAD
Spread / Average Target 211%
EPS Revisions
Managers and Directors
Álvaro F. Torres Chief Executive Officer & Director
Joel Friedman Chief Financial Officer
Chris Naprawa Chairman
Jairo Espinoza Vice President-Medical Affairs
Manuel Buendia Vice President-Operations
Sector and Competitors